Navigation Links
Autism focus of prize winning research
Date:11/27/2007

The differing rate of development of children with Autism is the focus of the research of one of the 2007 Michael Young Prize winners, awarded by the Economic and Social Research Council (ESRC) and the Young Foundation.

Previously most research in this area has focussed on the causes of autism rather than understanding it as a developmental disorder. By following a group of autistic children over a period of three years Dr Elizabeth Pellicano, from Bristol University, found that there was no uniform pattern of development.

Dr Pellicano commented "I am delighted to receive this prize. Not only does it recognise my work with children with autism, but it also recognises the significance of charting the development of autism the changes that take place across time, and the types of factors that play a role in shaping such changes.

My research findings bring hope to parents, teachers, and professionals working with young people with autism. They show that children with autism can make positive gains over a relatively short time period. In particular, childrens improvements in social interactions were especially impressive. They were chattier than previously, some were beginning to form friendships, and most showed fewer unusual behaviours and interests. We need to identify why these improvements took places, and how we can foster them further.

Teasing apart the types of factors that shape changes across time and particularly those that promote childrens well-being demands a research programme that follows children and families across time. This longitudinal research is of critical importance to the understanding of autism as a developmental condition.

Conceived in honour of the founder of the ESRC, the late Lord Michael Young, the prize aims to reward and encourage early career researchers whose work offers genuine new insights and is likely to have an impact beyond academia. Elizabeth wins 3,000 to help her communicate her research to users outside of academia.

Dr Pellicano said: "Winning the prize will enable me to hold a series of events inviting people with autism, parents and carers of children with autism, and policymakers to consider the changes and continuities that take place as children make the transition to adolescence and adulthood."

Benet Middleton, National Autistic Society Director of Communications, said: There is an urgent need for more research into autism to help us better understand and respond to this very complex, lifelong and disabling condition. We are really pleased that Dr Pellicanos work has been recognised and awarded accordingly. We look forward to seeing further work and events from Dr Pellicano and wish her every success with future research.


'/>"/>

Contact: Alexandra Saxon
alexandra.saxon@esrc.ac.uk
01-793-413-032
Economic & Social Research Council
Source:Eurekalert

Related medicine news :

1. Research may unlock mystery of autisms origin in the brain
2. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
3. Rain Man mice provide model for autism
4. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
5. Study shows autism symptoms can improve into adulthood
6. Brain Imaging Expert Recruited to Study Autism at The Childrens Hospital of Philadelphia
7. USC granted $8.4 million for autism research
8. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
9. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
10. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
11. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: